Results 101 to 110 of about 31,032 (201)

A case report of vanishing bile duct syndrome after exposure to pexidartinib (PLX3397) and paclitaxel. [PDF]

, 2019
Pexidartinib (PLX3397) is a small molecule tyrosine kinase and colony-stimulating factor-1 inhibitor with FDA breakthrough therapy designation for tenosynovial giant-cell tumor, and currently under study in several other tumor types, including breast ...
Chien, A Jo, Esserman, Laura J, Hyland, Colby, Piawah, Sorbarikor, Rugo, Hope S, Umetsu, Sarah E   +5 more
core  

Effects of letrozole, non-steroidal aromatase inhibitor, on serum sex steroid levels, oocyte diameter and gonadosomatic index (GSI) in rainbow trout (Oncorhynchus mykiss) [PDF]

, 2015
The objective of this study was to contribute to investigate the efficacy of letrozole, a potent non-steroidal aromatase inhibitor, on serum sex steroid levels and oocyte growth in rainbow trout females.
Akbary, P., Akhlaghi, M., Majazi Amiri, B., Mirvaghefi, A.   +3 more
core  

Preparation of UiO-66 loaded Letrozole nano-drug delivery system: enhanced anticancer and apoptosis activity

AMB Express
The use of drug delivery systems in targeting and achieving the targeting of drugs in treating diseases, especially cancer, has attracted the attention of researchers. Letrozole is one of the drugs for the treatment of breast cancer.
Maryam Ronaghi, Ramtin Hajibeygi, Reza Ghodsi, Akram Eidi, Ronak Bakhtiari   +4 more
doaj   +1 more source

Individualisation of the Dose of Letrozole for Ovulation Induction in Infertile Women with Polycystic Ovary Syndrome Based on Clinical and Ultrasonography Criteria: A Cohort Study

Journal of Human Reproductive Sciences
Background: Conventionally, letrozole for ovulation induction (OI) in polycystic ovary syndrome (PCOS) is started at a dose of 2.5 mg, which is gradually escalated depending on the follicular response.
Pratyasha Peepal, Padmalaya Thakur, Anubhuti Patel, Jyotiranjan Sahoo, Sujata Pradhan, Manisha Sahu   +5 more
doaj   +1 more source

Letrozole induced Necrotizing Cutaneous Vasculitis: A Rare Entity

Clinical Dermatology Review
Cutaneous small vessel vasculitis (CSVV) could be due to varied etiologies of which drug induced CSVV is a prime cause. It commonly presents as purpura but necrotizing lesions can be an uncommon presentation of the disease.
Liza Mohapatra, Soumya Surath Panda, Manoj Kumar Nayak, Kallolinee Samal   +3 more
doaj   +1 more source

Systemic Therapy in Endometrial Cancer: Recent Advances. [PDF]

, 2013
Endometrial cancer is a chemosensitive disease. Studies have established a clear benefit of chemotherapy in advanced stages and trials are ongoing to define its role in early stages as well.
Bhise, R, Guru Prasad B, B, Kundargi, R, Lakshmaia, KC, Purohit, S, Shetty, R   +5 more
core   +1 more source

The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review. [PDF]

Turk J Obstet Gynecol
Aydın G, Hatırnaz Ş, Saynur Hatırnaz E, Çetinkaya MB, Akdeniz M, Dokuzeylül Güngör N, Güler O, Merdanoğlu MA, Uzun A, Eroğlu S, Tosun Ö, Bahadırlı A, Yurtçu E, Keyif B, Güvey H, Gürkan N, Karlı P, Yılmaz Z, Baldini GM, Tavuz Aİ, Sparic R, Tabakova N, Tinelli A, Cao M, Ta SL, Hatırnaz O, Dahan M.   +26 more
europepmc   +1 more source

Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism-Based Therapeutic Approach. [PDF]

Obstet Gynecol Int
Rai SK, Kumar R, Khan MI, Kumar A.
europepmc   +1 more source

Advanced Management of Severe Adenomyosis in IVF: A Personalized Approach With Extended GnRH Agonist and Letrozole Therapy. [PDF]

Case Rep Obstet Gynecol
Fatemi C, Edades J, ElKhatib I, Ruiz F, Marques LM, Melado L.   +5 more
europepmc   +1 more source